Altria (MO) Q3 2026 Earnings: Duty Drawback Drives Profit Growth

Altria (MO) Q3 2026 earnings show that duty drawback on imported cigarettes drove most of the quarter's profit growth. Altria reported results for the third quarter of 2026 (July to September) on October 29, 2026, through its earnings release (8-K), its 10-Q and its earnings call, and raised its full-year guidance [1][2][3]. Earlier research had focused on three questions: whether Marlboro price increases could keep outrunning lower volume and the shift to discount brands, whether on! nicotine pouches could absorb the decline in moist smokeless tobacco, and whether the planned second-half increase in duty drawback would arrive. The drawback arrived as planned. Adjusted diluted EPS was $1.52, up 4.8% year over year, and full-year guidance rose to $5.66-$5.74 [1]. Cigarette volume held up better than feared, but cigarette profit excluding the drawback was roughly flat, and oral tobacco kept declining. Near-term earnings look more secure, while profit growth now depends much more on the drawback.

Altria is the largest US tobacco company, and almost all of its revenue comes from the United States. Its brands include Marlboro cigarettes, Copenhagen and Skoal moist smokeless tobacco, and on! nicotine pouches [4]. The company makes most of its money by raising cigarette prices each year to offset falling volume. In the third quarter the smokeable products segment accounted for about 87.5% of revenue net of excise taxes, with an adjusted operating companies income (OCI) margin of 64.5% [1].

Duty drawback became the main source of profit growth

The drawback benefit grew sharply in the third quarter. PM USA's contract-manufactured export cigarettes, made for third parties that sell outside the US, reached 1.595 billion sticks, compared with 311 million a year earlier and 736 million in the second quarter [2][5]. Higher export volume lets the company claim larger refunds of duties and excise taxes paid on imported cigarettes. Those refunds added $104 million to smokeable segment OCI year over year in the third quarter, after $78 million in the first half [2].

The drawback covered almost all of the segment's profit growth. Smokeable adjusted OCI was $3.072 billion, up $116 million, and $104 million of that increase came from the drawback [1][2]. At a 23% tax rate and 1.669 billion shares, the drawback added an estimated $0.05 per share, most of the $0.07 increase in adjusted EPS; higher earnings from the ABI investment also contributed [1][3]. This per-share figure is an estimate, not a company disclosure.

Whether this benefit lasts depends on contract-manufacturing agreements and the current refund rules. In the second quarter the company said it expected the second-half benefit to be more balanced between the third and fourth quarters, and management said on the third-quarter call that this expectation had not changed [6][3]. The contract-manufacturing agreement with Philip Morris International (PMI) does not begin until 2027, and management gave no size for it [3]. Altria discloses only the year-over-year change in refunds, not the total amount, and lists changes in tax law as a risk [2].

Cigarette volume beat fears, but core profit was flat

Cigarette volume and share were better than earlier concerns suggested. Adjusted for trade inventory movements, Altria's domestic cigarette shipments fell an estimated 4% in the third quarter, against an industry decline of about 5%. Marlboro shipments fell 6.4%, compared with a 7.4% decline in the second quarter [1][7]. Marlboro's share of the premium segment rose to 60.0%, which management attributed to Marlboro Cowboy Cut, a lower-priced premium option [1][3].

Lower volume and the mix shift toward discount brands absorbed most of the revenue gained from higher prices. Pricing added $290 million to segment revenue in the quarter, while lower volume and a higher share of discount cigarettes reduced it by $254 million. At the OCI level, costs rose another $80 million, mainly manufacturing [2]. Excluding the drawback, smokeable OCI rose only about $12 million, roughly flat, and the margin widened by just 0.1 percentage point [1][2].

on! shipments rose, but retail share has not followed

Helix completed the national expansion of 12-milligram on! PLUS in the third quarter, but retail results have not improved yet [3]. on! shipped 47.8 million cans, up 13.3% year over year but below 49.9 million cans in the second quarter. Its share of the nicotine pouch category fell to 13.5%, down 0.9 percentage points from the prior quarter [1][8]. Management acknowledged that shipments included pipeline inventory for the new products but said it was not significant [3]. Oral tobacco adjusted OCI was $443 million, down 3.7%, and its margin fell 2.8 percentage points [1].

Conclusion

This report strengthens the case for Altria's near-term earnings, but the source of profit growth has changed. Most of the new profit came from a refund driven by contracts and tax rules, and it does not reflect consumer demand. Cigarette pricing only barely offset the pressure from volume, mix and costs, and oral tobacco still weighed on profit. The drawback also reduced cash paid for excise taxes; operating cash flow for the first nine months was $6.151 billion [2]. Over the same period Altria paid $5.3 billion in dividends, and its board expanded the share repurchase authorization by $1 billion [1]. Based on full-year guidance, fourth-quarter adjusted EPS works out to about $1.33-$1.41 [1]. The conclusion would be reinforced if the fourth-quarter drawback matches the third quarter, cigarette profit excluding the drawback returns to growth, and on! retail share recovers. A smaller drawback or further share losses would weaken it.

Sources

• [1] MO 8-K filed 2026-10-29 · Q3 2026 earnings release (EX-99.1)
• [2] MO 10-Q filed 2026-10-29 · Q3 2026 MD&A
• [3] MO Q3 2026 earnings call 2026-10-29 · transcript
• [4] MO 10-K filed 2026-02-25 · business and operating companies
• [5] MO 10-Q filed 2026-07-30 · contract manufactured export cigarettes
• [6] MO 8-K filed 2026-07-30 · FY2026 guidance assumptions and drawback timing
• [7] MO 8-K filed 2026-07-30 · Q2 2026 cigarette shipment volume
• [8] MO 8-K filed 2026-07-30 · Q2 2026 oral shipment volume by brand